AbbVie
ABBV
#32
Rank
โ‚น37.928 T
Marketcap
โ‚น21,467
Share price
1.05%
Change (1 day)
33.64%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น353.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น628.24 B77.53%
2024 โ‚น353.88 B-40.54%
2023 โ‚น595.20 B-53.62%
2022 โ‚น1.283 T3.76%
2021 โ‚น1.236 T282.25%
2020 โ‚น323.60 B-59.67%
2019 โ‚น802.42 B62.13%
2018 โ‚น494.92 B-32.74%
2017 โ‚น735.86 B-1.99%
2016 โ‚น750.81 B18.65%
2015 โ‚น632.81 B180.5%
2014 โ‚น225.60 B-55.57%
2013 โ‚น507.77 B-6.86%
2012 โ‚น545.19 B56.05%
2011 โ‚น349.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.008 T 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.964 T 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น865.37 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น154.56 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น932.99 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น913.94 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.396 T 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น953.41 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น76.07 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA